• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌中h-warts/LATS1基因的分子分析。

Molecular analysis of the h-warts/LATS1 gene in human breast cancer.

作者信息

Morinaga N, Shitara Y, Yanagita Y, Koida T, Kimura M, Asao T, Kimijima I, Takenoshita S, Hirota T, Saya H, Kuwano H

机构信息

Department of Surgery I, Faculty of Medicine, Gunma University, Maebashi, Gunma 371-8511, Japan.

出版信息

Int J Oncol. 2000 Dec;17(6):1125-9. doi: 10.3892/ijo.17.6.1125.

DOI:10.3892/ijo.17.6.1125
PMID:11078797
Abstract

Loss of heterozygosity (LOH) on chromosome 6q is often observed in breast cancer, suggesting the existence of a putative tumor suppressor. Recently, a human homolog of the Drosophila warts tumor suppressor gene, h-warts/LATS1, was identified and mapped at chromosome 6q24-25.1. Mutation analysis of the h-warts/LATS1 was performed using 25 breast cancer tissues by RT-PCR SSCP analysis. Although LOH of the h-warts/LATS1 was found in one patient, no mutations were found. Two polymorphisms were found, but neither of them caused amino acid substitutions. Further investigations are necessary to elucidate the role of the h-warts/LATS1 gene in the carcinogenesis of breast cancer.

摘要

6号染色体长臂杂合性缺失(LOH)在乳腺癌中经常被观察到,这表明存在一个假定的肿瘤抑制基因。最近,果蝇warts肿瘤抑制基因的人类同源物h-warts/LATS1被鉴定出来,并定位在6号染色体长臂24-25.1区域。通过逆转录聚合酶链反应-单链构象多态性分析(RT-PCR SSCP分析),对25个乳腺癌组织进行了h-warts/LATS1的突变分析。虽然在一名患者中发现了h-warts/LATS1的杂合性缺失,但未发现突变。发现了两个多态性,但它们都没有导致氨基酸替换。需要进一步研究以阐明h-warts/LATS1基因在乳腺癌致癌过程中的作用。

相似文献

1
Molecular analysis of the h-warts/LATS1 gene in human breast cancer.人乳腺癌中h-warts/LATS1基因的分子分析。
Int J Oncol. 2000 Dec;17(6):1125-9. doi: 10.3892/ijo.17.6.1125.
2
Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma.
Lab Invest. 2002 Oct;82(10):1427-35. doi: 10.1097/01.lab.0000032381.68634.ca.
3
Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1.
Genomics. 1994 Sep 1;23(1):163-7. doi: 10.1006/geno.1994.1473.
4
Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.非小细胞肺癌和乳腺癌中p53同源物p51A/TAp63γ的突变分析。
Oncogene. 1999 Jun 24;18(25):3761-5. doi: 10.1038/sj.onc.1202972.
5
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.ATBF1和NQO1作为乳腺癌16号染色体臂等位基因缺失的候选靶点:不存在ATBF1体细胞突变且C609T NQO1多态性无作用
BMC Cancer. 2008 Apr 16;8:105. doi: 10.1186/1471-2407-8-105.
6
Overexpression of BRCA2 gene in sporadic breast tumours.散发性乳腺肿瘤中BRCA2基因的过表达。
Oncogene. 1999 Sep 16;18(37):5232-8. doi: 10.1038/sj.onc.1202903.
7
Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p.对19p存在杂合性缺失的家族性乳腺癌患者进行STK11/LKB1基因的种系突变筛查。
Clin Genet. 2000 May;57(5):394-7. doi: 10.1034/j.1399-0004.2000.570511.x.
8
Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor.桩蛋白是一种肌动蛋白丝组装调节剂,通过与h-warts/LATS1肿瘤抑制因子相互作用靶向有丝分裂器。
J Cell Biol. 2000 May 29;149(5):1073-86. doi: 10.1083/jcb.149.5.1073.
9
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.启动子高甲基化导致人乳腺癌中LATS1和LATS2 mRNA表达下调及其与生物学侵袭性表型的关联
Clin Cancer Res. 2005 Feb 15;11(4):1380-5. doi: 10.1158/1078-0432.CCR-04-1773.
10
Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.13q14处杂合性缺失与人类乳腺癌中RB1基因表达不足相关。
Mol Carcinog. 2000 Nov;29(3):151-8.

引用本文的文献

1
Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.LATS1和LATS2的缺失通过增强AKT活性和PD-L1表达促进卵巢肿瘤形成。
Oncogene. 2025 Apr 12. doi: 10.1038/s41388-025-03387-z.
2
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.生物分子凝聚物的新兴调控机制与功能:对治疗靶点的启示
Signal Transduct Target Ther. 2025 Jan 6;10(1):4. doi: 10.1038/s41392-024-02070-1.
3
WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
WWP2 通过促进 LATS1 蛋白的泛素化和降解来推动胃癌的进展。
Cell Commun Signal. 2023 Feb 17;21(1):38. doi: 10.1186/s12964-023-01050-2.
4
Outcome in serous ovarian cancer is not associated with LATS expression.浆液性卵巢癌的预后与 LATS 表达无关。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2737-2749. doi: 10.1007/s00432-019-03037-4. Epub 2019 Oct 4.
5
miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2.微小RNA-363通过靶向Hippo信号通路成员大肿瘤抑制因子2赋予卵巢癌对紫杉烷的抗性。
Oncotarget. 2018 Jul 10;9(53):30053-30065. doi: 10.18632/oncotarget.25698.
6
Clinicopathological Significance of Large Tumor Suppressor () Expression in Gastric Cancer.大肿瘤抑制因子()在胃癌中的临床病理意义
J Gastric Cancer. 2017 Dec;17(4):363-373. doi: 10.5230/jgc.2017.17.e41. Epub 2017 Dec 26.
7
LATS1 suppresses proliferation and invasion of cervical cancer.大肿瘤抑制因子1(LATS1)抑制宫颈癌的增殖和侵袭。
Mol Med Rep. 2017 Apr;15(4):1654-1660. doi: 10.3892/mmr.2017.6180. Epub 2017 Feb 8.
8
Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.大肿瘤抑制因子1的缺失通过上调YAP信号促进胃癌细胞的生长和转移。
Oncotarget. 2016 Mar 29;7(13):16180-93. doi: 10.18632/oncotarget.7568.
9
Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.LATS1 TSG 在结直肠癌中的低表达与启动子超甲基化有关。
World J Gastroenterol. 2013 Jul 21;19(27):4363-73. doi: 10.3748/wjg.v19.i27.4363.
10
Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.下调 Yes 相关蛋白 1 的表达可降低胰腺癌细胞的增殖和克隆形成能力。
PLoS One. 2012;7(3):e32783. doi: 10.1371/journal.pone.0032783. Epub 2012 Mar 1.